Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
İsmail Akaltun, Tayfun Kara & Hamza Ayaydın. (2018) A case of an 11-year-old girl diagnosed with OCD developing giggle incontinence following addition of aripiprazole to treatment. Psychiatry and Clinical Psychopharmacology 28:3, pages 343-345.
Read now
Read now
Articles from other publishers (21)
Ali Caykoylu, Ersin Hatice Karslioglu, Nese Burcu Bal & Cagla Kocberber. (2022) When and why aripiprazole causes extrapyramidal side effects: Three cases and mini review. Psychiatry Research Case Reports 1:2, pages 100066.
Crossref
Crossref
Marta Balog, Allison Anderson, Thiago C. Genaro-Mattos, Zeljka Korade & Karoly Mirnics. (2022) Individual and simultaneous treatment with antipsychotic aripiprazole and antidepressant trazodone inhibit sterol biosynthesis in the adult brain. Journal of Lipid Research 63:8, pages 100249.
Crossref
Crossref
Upinder Kaur, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Indrajeet Singh Gambhir & Sankha Shubhra Chakrabarti. (2020) Aripiprazole-induced Parkinsonism with pregabalin as a confounder. Acta Neurologica Belgica 121:5, pages 1351-1356.
Crossref
Crossref
Jacob Yomtoob, Kimberly Koloms & Danny Bega. (2018) DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice. Parkinsonism & Related Disorders 53, pages 37-41.
Crossref
Crossref
Roger Hudson, Yan Zhou & Francesco Leri. (2017) The combination of escitalopram and aripiprazole: Investigation of psychomotor effects in rats. Journal of Psychopharmacology 31:12, pages 1605-1614.
Crossref
Crossref
Hae-Young Park, Ji-Won Park, Hyun Soon Sohn & Jin-Won Kwon. (2017) Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case–Control Study in South Korea. Drug Safety 40:11, pages 1109-1118.
Crossref
Crossref
Željka Korade, Wei Liu, Emily B. Warren, Kristan Armstrong, Ned A. Porter & Christine Konradi. (2017) Effect of psychotropic drug treatment on sterol metabolism. Schizophrenia Research 187, pages 74-81.
Crossref
Crossref
Karim Selfani, Valérie L. Soland, Sylvain Chouinard & Philippe Huot. (2017) Movement Disorders Induced by the “Atypical” Antipsychotic Aripiprazole. The Neurologist 22:1, pages 24-28.
Crossref
Crossref
Y. W. Francis Lam. (2017) Risk of extrapyramidal reactions with aripiprazole. The Brown University Psychopharmacology Update 28:1, pages 2-3.
Crossref
Crossref
Mahyar Etminan, Ric M. Procyshyn, Ali Samii & Bruce C. Carleton. (2016) Risk of Extrapyramidal Adverse Events With Aripiprazole. Journal of Clinical Psychopharmacology 36:5, pages 472-474.
Crossref
Crossref
MATTHEW MACALUSO, ALEXANDRA FLYNN & SHELDON PRESKORN. (2016) Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data. Journal of Psychiatric Practice 22:3, pages 203-220.
Crossref
Crossref
Rakesh Goyal & Salam Hemabati Devi. (2014) A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow Up. Clinical Psychopharmacology and Neuroscience 12:1, pages 69-71.
Crossref
Crossref
Wei-Yi Wu, Hung-Yu Chan & Happy Kuy-Lok Tan. (2013) Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder. Acta Neuropsychiatrica 26:1, pages 61-64.
Crossref
Crossref
Jacob Alexander & Samantha Bickerstaff. (2012) Aripiprazole induced tardive dyskinesia-accruing evidence. Australian & New Zealand Journal of Psychiatry 47:3, pages 289-290.
Crossref
Crossref
Francisco Cardoso. 2012. Handbook of Dystonia. Handbook of Dystonia
297
306
.
Pierre J. Blanchet. 2012. Hyperkinetic Movement Disorders. Hyperkinetic Movement Disorders
187
220
.
Y. Auxéméry. (2011) Dyskinésies tardives secondaires aux neuroleptiques et antipsychotiques : quelles perspectives thérapeutiques ?. Annales Médico-psychologiques, revue psychiatrique 169:8, pages 528-535.
Crossref
Crossref
Brian D. Berman. (2011) Neuroleptic Malignant Syndrome. The Neurohospitalist 1:1, pages 41-47.
Crossref
Crossref
Maria Sierra Peña, Toby C. Yaltho & Joseph Jankovic. (2010) Tardive dyskinesia and other movement disorders secondary to aripiprazole. Movement Disorders 26:1, pages 147-152.
Crossref
Crossref
Pasquale De Fazio, Paolo Girardi, Giuseppe Maina, Massimo Carlo Mauri, Mauro Mauri, Palmiero Monteleone, Giulia Ida Perini, Giulio Perugi & Alessandro Rossi. (2010) Aripiprazole in Acute Mania and Long-Term Treatment of Bipolar Disorder. Clinical Drug Investigation 30:12, pages 827-841.
Crossref
Crossref
Deborah Hall, Laura Pickler, Karen Riley, Flora Tassone & Randi Hagerman. (2010) Parkinsonism and cognitive decline in a fragile X mosaic male. Movement Disorders 25:10, pages 1523-1524.
Crossref
Crossref